Influence of matrix-metalloproteinase inhibitor on the interaction between cancer cells and matrigel

被引:0
|
作者
叶腾 [1 ]
叶方富 [2 ,3 ]
邱峰 [1 ,4 ]
机构
[1] First Clinical Medical College,Nanchang University
[2] Beijing National Laboratory for Condensed Matter Physics,Institute of Physics,Chinese Academy of Sciences
[3] Wenzhou Institute,University of Chinese Academy of Sciences
[4] Department of Oncology,First Affiliated Hospital of Nanchang University
基金
中国国家自然科学基金;
关键词
cancer cells; matrigel; matrix metalloproteinase(MMP) inhibitor; migration;
D O I
暂无
中图分类号
R730.2 [肿瘤病理学、病因学];
学科分类号
100214 ;
摘要
Various behaviors of cancer cells are strongly influenced by their interaction with extracellular matrices(ECM). We investigate how this interaction may be influenced if the cancer cells’ ability of secreting matrix metalloproteinases(MMPs)to degrade ECM is inhibited by adding the MMP inhibitor. We use MDA-MB-231-GFP cells as model cells and use matrigel to mimic ECM. It is found that the added MMP inhibitor significantly reduces the migration speed of cancer cells covered by matrigel but has little influence on the migration persistence and shape factor of the cells and that with the MMP inhibitor added the presence of matrigel on the top has no influence on the migration speed of the cells but increases the cells’ shape factor and migration persistence.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 50 条
  • [1] Influence of matrix-metalloproteinase inhibitor on the interaction between cancer cells and matrigel
    Ye, Teng
    Ye, Fangfu
    Qiu, Feng
    CHINESE PHYSICS B, 2020, 29 (06)
  • [2] The matrix-metalloproteinase inhibitor RECK affects prostate cancer progression
    Rabien, A.
    Ergun, B.
    Lein, M.
    Stephan, C.
    Jung, K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 175 - 175
  • [3] Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment
    Rha, SY
    Jeung, HC
    Roh, JK
    Kim, JJ
    Noh, SH
    Min, JS
    Kim, BS
    Chung, HC
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2002, 10 (03) : 251 - 256
  • [4] High tissue inhibitor of matrix-metalloproteinase 2 expression correlates with poor prognosis in breast cancer
    Heyman, T.
    Joseph, C.
    Craze, M.
    Green, A.
    Nolan, C.
    Rueda, O.
    Provenzano, E.
    Rakha, E.
    Ellis, I. O.
    Mukherjee, A.
    VIRCHOWS ARCHIV, 2020, 477 : S52 - S52
  • [5] Association between matrix-metalloproteinase polymorphisms and prostate cancer risk: a meta-analysis and systematic review
    Zhou, Hongxing
    Zhu, Xuming
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5247 - 5259
  • [6] The matrix-metalloproteinase ADAM15 mediates platelet adhesion to endothelial cells
    Langer, H
    Schutz, C
    Schneider, S
    Lorenz, M
    Massberg, S
    Gawaz, M
    EUROPEAN HEART JOURNAL, 2004, 25 : 92 - 93
  • [7] Matrix-metalloproteinase expression and gelatinase activity in the avian retina and their influence on Muller glia proliferation
    Campbell, Warren A.
    Deshmukh, Ameya
    Blum, Sydney
    Todd, Levi
    Mendonca, Ninoshka
    Weist, Jessica
    Zent, Joshua
    Hoang, Thanh V.
    Blackshaw, Seth
    Leight, Jennifer
    Fischer, Andy J.
    EXPERIMENTAL NEUROLOGY, 2019, 320
  • [9] Influence of matrigel on the shape and dynamics of cancer cells
    Ye, Teng
    Qiu, Feng
    CHINESE PHYSICS B, 2019, 28 (10)
  • [10] Testis peritubular myoid cells increase their motility and express matrix-metalloproteinase 9 (MMP-9) after interaction with embryonal carcinoma cells
    Moreno-Ruiz, P.
    Arluzea, J.
    Silvan, U.
    Diez-Torre, A.
    Andrade, R.
    Bonilla, Z.
    Diaz-Nunez, M.
    Silio, M.
    Arechaga, J.
    ANDROLOGY, 2016, 4 (01) : 111 - 120